Clinical Trials in Hubei, China
6 recruiting
Showing 1–13 of 13 trials
Recruiting
Not Applicable
The Prevalence, Disease Burden and Prognosis of COPD in Patients With Cardiovascular Diseases
Cardiovascular Diseases
AstraZeneca3,000 enrolled69 locationsNCT06909773
Recruiting
Phase 1
Preliminary Human Trials of F230 Tablets
Pulmonary Hypertension
Beijing Continent Pharmaceutical Co, Ltd.136 enrolled1 locationNCT06899815
Recruiting
Phase 1Phase 2
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
Triple-Negative Breast CancerEndometrial CancerPrimary Peritoneal Carcinoma+12 more
Genmab764 enrolled67 locationsNCT05579366
Recruiting
Phase 2
DB-1311 in Combination With BNT327 or DB-1305 in Advanced/Metastatic Solid Tumors
Solid Tumors
DualityBio Inc.492 enrolled37 locationsNCT06953089
Recruiting
Phase 3
Evaluation of Lasofoxifene Combined With Abemaciclib Compared With Fulvestrant Combined With Abemaciclib in Locally Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation
Metastatic Breast Cancer
Sermonix Pharmaceuticals Inc.500 enrolled222 locationsNCT05696626
Recruiting
Early Phase 1
This is an Early Exploratory Study to Assess the Tolerability and Safety of GC012F in Patients With Multiple Sclerosis
Multiple Sclerosis
Daishi Tian15 enrolled1 locationNCT07303790
Recruiting
Phase 1
A Trial of Hydroxynidone Capsules in Single-dose Administration for Patients With Renal Insufficiency
Renal Insufficiency, Chronic
Beijing Continent Pharmaceutical Co, Ltd.56 enrolled1 locationNCT07262333
Recruiting
Phase 2
A Study for Subjects With Prostate Cancer Who Previously Participated in an Enzalutamide Clinical Study
Prostate Cancer
Astellas Pharma Global Development, Inc.900 enrolled241 locationsNCT02960022
Recruiting
Phase 2
The Combination of Adebrelimab and TP Regimen for Neoadjuvant Therapy in Patients With Stage IVB Oral Squamous Cell Carcinoma
Clinical IVb Stage Oral Squamous Cell Carcinomas Patients
Hospital of Stomatology, Wuhan University35 enrolled1 locationNCT06277791
Recruiting
Phase 1Phase 2
A Study of JAB-21822 in Advanced or Metastatic NSCLC With KRAS p.G12C and STK11 Co-mutation and Wild-type KEAP1
Non-small Cell Lung Cancer
Allist Pharmaceuticals, Inc.104 enrolled21 locationsNCT05276726
Recruiting
Phase 1
A Study of XS-04 in Patients with Relapsed or Refractory Hematologic Malignancies
Acute Myeloid LeukemiaMyelodysplastic SyndromeB-cell Lymphoma
NovaOnco Therapeutics Co., Ltd.168 enrolled4 locationsNCT06820268
Recruiting
Phase 3
89Zr-TLX250 for PET/CT Imaging of ccRCC - ZIRCON-CP Study
Clear Cell Renal Cell Carcinoma
Telix Pharmaceuticals (Innovations) Pty Limited82 enrolled8 locationsNCT06750419
Recruiting
Phase 2
Short-Course Radiotherapy Followed by Neoadjuvant Chemotherapy, HLX07and Serplulimab in LARC
Rectal Cancer
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology29 enrolled3 locationsNCT06542588